The demand for infection surveillance systems is increasing as hospital-acquired illnesses such surgical site infections and urinary tract infections are becoming more common. These solutions are used to evaluate the preventative measures and diagnose the illnesses
Covid 19 Impact & Market Status
As a result of the COVID-19 epidemic, the global market for infection surveillance services is anticipated to grow favourably. The COVID-19 pandemic has put a strain on healthcare systems throughout the world and raised the possibility that COVID-19 patients would get a healthcare-associated illness. The rise in the prevalence of healthcare-associated infections, increased funding from private and public organisations for various programmes related to infection surveillance, an increase in the number of surgical procedures, an increase in the population of elderly people who are more vulnerable to healthcare-associated infections, and an increase in the adoption of infection surveillance software among healthcare professionals are the major elements influencing the development of the worldwide market for infection surveillance services.
Emergence as a Lucrative Segment in the Industry
Due to the rising prevalence of Obamacare infections, the presence of key players, the rise in healthcare spending, advancements in analytical & infectious surveillance solutions, and the growing number of government projects to prevent healthcare-associated infections in the region, North America accounted for a sizeable portion of the infection surveillance market globally in 2020 and is anticipated to maintain its dominance during the forecast timeframe. However, Asia-Pacific is anticipated to have the highest CAGR of 14.6 percent till 2029 due to a rise in the rate of hospital acquired infections, an increase in the geriatric population, an increase in the tendency of consciousness, and an increase in the adoptive parents of infection surveillance software among health professionals.
The software segment is accounted for the highest market share
Due to the rising frequency of healthcare-associated infections and the rising demand for infection monitoring software by the healthcare sectors, the software segment, depending on the offering, led the market in 2020 and is predicted to maintain this trend over the forecast period. However, the services segment is anticipated to undergo huge rise in the infection surveillance services market throughout the forecast period due to rising medical service market, an uptick in the prevalence of surgery center infections, and a climb in the adoption of infection surveillance source code among medical practitioners.
These systems are particularly helpful for healthcare organisations because to several advantages including precise employee health information, surgical databases, and real-time medical records.
They are also required to assist in the diagnosis of bacteria that are resistant to antibiotics and illnesses brought on by unsterilized medical equipment. These systems are particularly helpful for healthcare organisations because to several advantages including precise employee health information, surgical databases, and real-time medical records. We use surveillance techniques to control infection patterns. The improved analytics capabilities of IT systems benefits industry expansion. Hospitals have emerged as the leading end-user in these sectors because to their high adoption rate for handling real-time pharmacy administration and preserving electronic medical records. We use surveillance techniques to control infection patterns. The improved analytics capabilities of IT systems benefits industry expansion. Because of its widespread use for managing real-time pharmacy administration and maintaining electronic medical records, hospitals have emerged as the industry's top end-user. A substantial portion of the market's revenue is anticipated to originate from North America and Europe as a result of the high adoption rate of these surveillance systems, which has been supported by the governing authorities. Established businesses invest in emerging markets to improve their competitiveness.
In 2022, the market for infection surveillance services was estimated to be worth 407.06 Million, and by 2029, it is expected to reach 1,700 USD Million.
Becton, Dickinson and Company, Premier, Inc., Wolters Kluwer N.V., Cerner Corporation, Baxter International Inc., GOJO Industries, Inc., Sunquest, Deb Group Ltd., BioVigil Healthcare Systems, RLDatix, IBM Corporation, Vecna Technologies, Inc., VigiLanz Corporation, and Ecolab Inc. are some of the market's well-known competitors
Latest Innovation in the Infection Surveillance Services Market: A Snapshot
- According to the Centers for Disease Control (CDC) and Prevention, healthcare-associated infections cause approximately 1.7 million illnesses and 99,000 fatalities annually in the United States. For particular, BioMerieux, a leader in the field of in vitro diagnostics for infectious diseases, just unveiled CLARION, an operating system (SaaS) platform for contagious disease diagnostics that links diagnostic data in the United States. The increase in bacterial resistance to antibiotics is another way to drive the market's ascent. Prolonged antibiotic therapy for Lyme disease was identified by the Association of Medical Microbiology and Infectious Disease Canada (AMMIC) as a contributing factor to healthcare-associated infectious illnesses in Canada in 2019.
Infection Surveillance Services Market Scope
|Forecast Unit||Value (USD)|
|Revenue forecast in 2028||USD 1,700 Million|
|Segment Covered||Type, Offerings, Application, Regions|
|Regions Covered||North America, Europe, Asia Pacific, South America, Middle East and South Africa|
|Key Players Profiled||Becton, Dickinson and Company, Premier, Inc., Wolters Kluwer N.V., Cerner Corporation, Baxter International Inc., GOJO Industries, Inc., Sunquest, Deb Group Ltd., BioVigil Healthcare Systems, RLDatix, IBM Corporation|
Key Segments of the Infection Surveillance Services Market
Type Overview, 2022-2029 (USD Million)
- Hospital-acquired Pneumonia
- Bloodstream Infections
- Surgical Site Infections
- Gastrointestinal Infections
- Urinary Tract Infections (UTIs)
Offerings Overview, 2022-2029 (USD Million)
Application Overview, 2022-2029 (USD Million)
- Hospitals & Clinics
- Ambulatory Surgical Centres & Academic Institutes
- Long-term Care Facilities
Regional Overview, 2022-2029 (USD Million)
- Rest of Europe
- Rest of Asia Pacific
- Rest of South America
Middle East and South Africa